Featured Study
Active Studies
-
Epstein-Barr Virus (EBV)
Support Groundbreaking Research by Participating in Our Mono Vaccine Study. Your involvement could help improve protection against infectious mononucleosis (mono) for young people everywhere.
Read more
Criteria & Qualifications: • You are eligible if you meet the study's age requirements (10-30 years old).
• Able to commit to the study duration, which involves attending study visits and participating in phone calls.
• Able to attend required study visits and participate in required phone calls over the study period.
Compensation: Contact us for more information. -
Pneumococcal Vaccine Study
Support groundbreaking research by participating in our Pneumococcal Vaccine Study. Your involvement could help improve vaccine protection for children everywhere.
Read more
Criteria & Qualifications: • Your child is eligible if they meet the study's age requirements.
• Able to commit to 7–8 study visits over a period of 16–19 months.
• Parent or guardian must be able to attend all 7–8 study visits over 16–19 months.
Compensation: Contact us for more information. -
Respiratory Syncytial Virus (RSV) Pediatric Study
We’re conducting a study to explore a new option for children with respiratory syncytial virus (RSV). This research aims to better understand how it can support recovery and overall health.
Read more
Criteria & Qualifications: • Must be under 18 years old.
• Diagnosed with RSV.
• May have health factors like certain medical conditions.
Compensation: Contact us for more information -
Respiratory Syncytial Virus (RSV) Trial
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with acute RSV infection.
• Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions.
Compensation: Contact us for more information -
Pediatric Obesity
This clinical trial is evaluating a new medication to improve health outcomes for adolescents living with obesity or overweight with weight-related health conditions. The goal is to assess how this treatment can reduce health risks and enhance quality of life.
Read more
Criteria & Qualifications: • Must be an adolescent.
• Living with obesity or overweight with related comorbidities.
• Not currently taking medications for weight management.
Compensation: Contact us for more information -
Obesity Trial
Join a clinical trial that aims to improve health outcomes for people living with obesity or being overweight. This study is testing a new medication to see how it can reduce health risks and improve the overall quality of life for individuals managing obesity.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Living with obesity or overweight.
• Not currently taking medications for weight loss.
Compensation: Contact us for more information -
NASH/MASH
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis.
• Cannot join if you have other liver diseases or a history of chronic alcohol use.
Compensation: Contact us for more information -
NASH
Help us improve treatment options for people with NASH and related health conditions. This clinical trial is studying a once-monthly therapy to reduce liver fat and improve metabolic health in diverse populations.
Read more
Criteria & Qualifications: • Adults diagnosed with NASH.
• Includes people with pre-diabetes or type 2 diabetes.
• Open to individuals seeking better liver and metabolic health management.
Compensation: Contact us for more information -
COVID-19 treatment Study
Participate in a COVID-19 treatment study to help prevent severe illness. Join us in advancing research for high-risk individuals.
Read more
Criteria & Qualifications: • Must be 18 years or older and diagnosed with COVID-19 within the last 4 days.
• Experiencing at least 2 symptoms like cough, fatigue, fever, or shortness of breath in the last 4 days.
• Have one or more high-risk factors such as advanced age (75+), immunosuppression, or certain chronic conditions like lung disease or obesity (BMI ≥ 35).
Compensation: Contact us for more information.
